Zobrazeno 1 - 10
of 38
pro vyhledávání: '"O P Markova"'
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 2, Pp 172-187 (2024)
INTRODUCTION. The current cell-based cartilage repair methods, such as autologous chondrocyte transplantation, are not sufficiently effective, and the surgery is painful and traumatic. Therefore, there is a need for a more effective cell therapy prod
Externí odkaz:
https://doaj.org/article/0044305a9bd74c4b994656cb0c2cae0f
Autor:
E. V. Zuev, O. L. Evdokimova, O. A. Markova, I. A. Korotkevich, T. V. Grigorieva, R. A. Khamitov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 3, Pp 275-289 (2023)
Scientific relevance. Intranasal vaccination may dramatically change current approaches to mass immunisation against various infections, shifting the focus from inducing systemic humoral and cellular immune responses to developing mucosal immunity an
Externí odkaz:
https://doaj.org/article/baa6ef9846c74f43b0c135803f7d7b34
Autor:
O. O. Markova
Publikováno v:
Вісник Харківського національного університету внутрішніх справ, Vol 101, Iss 2 (Part 2), Pp 151-162 (2023)
A comparative legal analysis of one of the stages of administrative procedure i.e. the stage of appeal against an administrative act has been carried out. The attention is focused on the study of the provisions of the FRG Law “On Administrative Pro
Externí odkaz:
https://doaj.org/article/b1d8d82e8d99439fa4f1d29d000f6151
Autor:
V. V. Ptushkin, A. D. Kulagin, E. A. Lukina, I. L. Davydkin, T. S. Konstantinova, V. S. Shamrai, N. V. Minaeva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borozinets
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 77-84 (2020)
Currently, the main pathogenetic method for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) is the treatment with recombinant monoclonal antibodies that block the C5 component of the complement system. Eculizumab is the first biotechnologi
Externí odkaz:
https://doaj.org/article/c8727c8295774e18b3a446395b05b823
Autor:
S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borоzinets, A. A. Kazarov, М. S. Pantyushenko
Publikováno v:
Онкогематология, Vol 14, Iss 4, Pp 73-83 (2019)
Background. Currently, the main treatment for Gaucher disease is enzyme replacement therapy. Recombinant glucocerebrosidase (imiglu-cerase) is the first biotechnological drug for enzyme replacement therapy with proven clinical efficacy and safety for
Externí odkaz:
https://doaj.org/article/3727d50786d248acb2c75158dae94797
Autor:
Sh. Erdes, T. V. Dubinina, E. M. Agafonova, D. G. Rumyantseva, S. Yu. Davidyan, E. V. Zemerova, A. I. Kulikov, O. G. Markova
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 307-311 (2019)
Objective: to evaluate the effect of golimumab (GLM) on the clinical, functional, and instrumental manifestations of coxitis in ankylosing spondylitis (AS).Subjects and methods. The non-interventional prospective multicenter cohort study GO-COX condu
Externí odkaz:
https://doaj.org/article/516f11e00cf24298bddd35890a341c49
Autor:
S. V. Lukicheva, O. Yu. Markova
Publikováno v:
Высшее образование в России, Vol 27, Iss 6, Pp 108-112 (2018)
The paper exploresthe system of factors influencing on motivation of workplace choice by graduates of technical higher education institution. The paper is based on the results of questioning of students of final courses of technical specialties. Prio
Externí odkaz:
https://doaj.org/article/421e2191aaf54399ad87a1df6a8bb796
Autor:
E. B. Starodubtseva, O. M. Markova
Publikováno v:
Мир новой экономики, Vol 0, Iss 4, Pp 108-113 (2018)
In the article the problems of formation and functioning of banking systems of the EAEU member States, their common features, peculiarities of development associated with the weak competitiveness of banks of individual countries and their involvement
Externí odkaz:
https://doaj.org/article/68f3863dd3694c4bb96d96c2f58a61f2
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 3, Pp 158-164 (2018)
The article describes a new method for measurement of monoclonal antibody Eculizumab concentration in human plasma in a range of 3-250 μg/ml. In this method we used an antibody Fab fragment, capable of binding to eculizumab specifically in human pla
Externí odkaz:
https://doaj.org/article/c9ab5b3ce71e41b2ba20cfcaf1469840
Autor:
N. I. Brico, N. N. Tsapkova, V. A. Sukhova, A. N. Gerasimov, R. V. Polybin, I. E. Turina, P. I. Dryagileva, N. V. Kholodnova, Yu. Yu. Khetagurov, I. V. Feldblum, A. V. Polushkina, L. N. Titova, K. A. Thapa, G. V. Sharuho, O. A. Rychkova, O. P. Markova, Yu. A. Kazyanov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 5, Pp 16-21 (2017)
Pneumococcal infections are among the most common infections are an important cause of morbidity and mortality worldwide, including Russia. At the end of 2014 in the national immunization schedule countries introduced vaccination against pneumococcal
Externí odkaz:
https://doaj.org/article/f1c1eb1b4cfb46a99a2a46914743f437